Accuracy of Implant Placement for Patients With Mandibular Reconstruction Using Dynamic Navigation and Static Guides
Evaluation of Accuracy of Implant Placement for Patients With Mandibular Reconstruction Using Dynamic Navigation Compared to Static Guides: a Parallel, Randomized Controlled Clinical Trial
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
To evaluate and compare the accuracy of implant placement using dynamic navigation technique versus static template technique in patients with bone tissue flap reconstruction of mandibular defects, thus further guiding the clinical application of dynamic navigation systems to assist in conventional implant placement in patients with mandibular defects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2024
CompletedFirst Posted
Study publicly available on registry
February 9, 2024
CompletedStudy Start
First participant enrolled
February 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedFebruary 9, 2024
November 1, 2023
10 months
February 1, 2024
February 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Three-dimensional implant placement accuracy of apical point
The postoperative cone beam computed tomography (CBCT) was aligned to the preoperative plan in specific software, and the three-dimensional coordinates of the preoperatively planned and actual postoperative implant placement positions were measured separately, from which the three-dimensional distance (in mm) between the apical point of the actual implant and the apical point of the virtual implant was calculated.
Postoperative day 2±1
Secondary Outcomes (5)
Three-dimensional implant placement accuracy of coronal point
Postoperative day 2±1
Three-dimensional implant placement angular accuracy
Postoperative day 2±1
Operation time
Intraoperative
Patient subjective satisfaction
Postoperative day 14±1
Failure rate during implant healing period
Postoperative day 90±7
Study Arms (2)
Dynamic navigation
EXPERIMENTALStatic template
ACTIVE COMPARATORInterventions
Osteotomy and implant placement with the guidance of dynamic navigation
Osteotomy and implant placement with the guidance of static template
Eligibility Criteria
You may qualify if:
- Male or female patients between the ages of 18 and 70 (inclusive)
- Mandibular defects (including Class I defects, limited to the body of the mandible; Class II defects, muscular-mandibular region defects and Class III defects, chin protrusion-muscular-mandibular region defects), which have been reconstructed by mandibular vascularization of free iliac bone, and fibular composite muscular flap grafts for greater than 3 months
- Normal mouth opening (≥ 40 mm)
- Trialists voluntarily signed an informed consent form before performing any research-related experimental steps.
You may not qualify if:
- Presence of localized inflammation in adjacent teeth, including uncontrolled periodontitis (periodontal probing to a depth of \>4 mm)
- Presence of untreated acute and chronic apical periodontitis in adjacent teeth
- Oral mucosal lesions (e.g., lichen planus)
- Adjacent teeth with space-occupying lesions (including cysts, tumors, etc.)
- Systemic diseases affecting bone healing, wound healing and dental implant treatment (e.g., uncontrolled diabetes mellitus, fasting blood glucose ≥ 8.8 mmol/L despite medication)
- Uncontrolled and unstabilized severe hypertension
- Contraindications to routine implant surgery and oral surgery
- Heart disease (Class II or above)
- Patients with liver or kidney insufficiency or abnormality
- Obese patients with body mass index (BMI) \> 28 kg/m2
- Patients with a history of full-dose radiotherapy, localized radiotherapy to the head or neck
- Patients requiring long-term high-dose steroid therapy
- Patients who are receiving or have received in the last 3 months medications (e.g., bisphosphonates) that may affect or promote bone metabolism
- Consecutive antibiotic therapy or chronic anti-inflammatory therapy (≥3 times per week) within the first 4 weeks of starting the procedure
- Alcohol or chronic substance abuse
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2024
First Posted
February 9, 2024
Study Start
February 29, 2024
Primary Completion
December 31, 2024
Study Completion
July 31, 2025
Last Updated
February 9, 2024
Record last verified: 2023-11